共 99 条
[1]
Lok AS(1991)Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 182-188
[2]
Liang RH(1997)Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan Ann Oncol 8 S107-307
[3]
Chiu EK(1999)Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem J Clin Oncol 17 394-1311
[4]
Wong KL(2000)Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors J Med Virol 62 299-127
[5]
Chan TK(2004)Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy Br J Cancer 90 1306-528
[6]
Todd D(1996)Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin’s lymphoma Blood 87 1202-1016
[7]
Kumagai K(2008)Changes of hepatitis B surface antigen seroprevalence in Korea, 1998–2005 Korean J Epidemiol 30 119-215
[8]
Takagi T(2008)Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy Ann Intern Med 148 519-546
[9]
Nakamura S(2006)Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection Aliment Pharmacol Ther 24 1003-563
[10]
Sawada U(2004)Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients Breast Cancer Res Treat 88 209-88